Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/XTL BIOPHARMACEUTICALS LTD/ 20-F

SEC Filing · 20-F

XTL BIOPHARMACEUTICALS LTD

SEC Filing

Filed Jun 30, 2026Accepted Jun 30, 2026, 5:24 PM EDTCIK 1023549Accession 0001213900-26-073831
View company →Permanent SEC source ↗
Share

Company context

Current securities

XTLBNASDAQ · ADR · Current

Recent company filings

  1. 6-K filingAug 5, 2026
  2. 6-K filingJul 21, 2026
  3. 6-K filingJun 30, 2026
  4. 6-K filingJun 29, 2026
  5. 6-K filingJun 23, 2026

As-filed source

Primary evidence
As filedOpen full document ↗